These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6468180)

  • 1. Progression of mammary adenocarcinomas as reflected by nuclear DNA content.
    Auer GU; Fallenius AG; Erhardt KY; Sundelin BS
    Cytometry; 1984 Jul; 5(4):420-5. PubMed ID: 6468180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of nuclear DNA content in mammary adenocarcinomas in humans.
    Auer G; Eriksson E; Azavedo E; Caspersson T; Wallgren A
    Cancer Res; 1984 Jan; 44(1):394-6. PubMed ID: 6690053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow-cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations.
    Ewers SB; Långström E; Baldetorp B; Killander D
    Cytometry; 1984 Jul; 5(4):408-19. PubMed ID: 6468179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Malignancy grading in breast cancer as assessed by nuclear DNA content].
    Nishi T; Okajima K; Taguchi T; Mizutani H; Sogabe T; Uragami I; Sekimoto T
    Nihon Geka Gakkai Zasshi; 1988 Apr; 89(4):576-81. PubMed ID: 3405196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of nuclear DNA content in primary and metastatic papillary thyroid carcinoma.
    Bäckdahl M; Cohn K; Auer G; Forsslund G; Granberg PO; Lundell G; Löwhagen T; Willems JS; Zetterberg A
    Cancer Res; 1985 Jun; 45(6):2890-4. PubMed ID: 3986815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The reliability of microspectrophotometric and flow cytometric nuclear DNA measurements in adenocarcinomas of the breast.
    Fallenius AG; Askensten UG; Skoog LK; Auer GU
    Cytometry; 1987 May; 8(3):260-6. PubMed ID: 3595349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal growth of atypical adenomatous hyperplasia of the lung: cytofluorometric analysis of nuclear DNA content.
    Nakayama H; Noguchi M; Tsuchiya R; Kodama T; Shimosato Y
    Mod Pathol; 1990 May; 3(3):314-20. PubMed ID: 2362938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The DNA profile of breast cancer in situ.
    Pallis L; Skoog L; Falkmer U; Wilking N; Rutquist LE; Auer G; Cedermark B
    Eur J Surg Oncol; 1992 Apr; 18(2):108-11. PubMed ID: 1582502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytospectrophotometric study of DNA content in dysplasia and breast cancer].
    Zolotarevskiĭ VB; Popov MS
    Arkh Patol; 1977 Jan; 39(1):25-31. PubMed ID: 190981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [DNA content in the nuclei of breast cancer cells and their metastases to the regional lymph nodes analyzed by impulse cytophotometry].
    Petrova AS; Zubrikhina GN; Koriakina RF; Murtskhvaladze GN
    Vopr Onkol; 1981; 27(1):27-32. PubMed ID: 7006214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence cytophotometric measurements of nuclear DNA in adenocarcinoma of the lung; relation of proliferative activity and DNA ploidy to prognosis.
    Blöndal T; Lindgren A
    Anal Quant Cytol; 1982 Sep; 4(3):225-32. PubMed ID: 7149488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear DNA content and nuclear atypia. Relation to survival in patients with breast adenocarcinoma and serious ovarian tumors.
    Erhardt K; Silfverswärd C; Auer G
    Anticancer Res; 1989; 9(5):1325-30. PubMed ID: 2589823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of nuclear DNA content to clinicopathologic features in colorectal cancer.
    Lanza G; Maestri I; Ballotta MR; Dubini A; Cavazzini L
    Mod Pathol; 1994 Feb; 7(2):161-5. PubMed ID: 8008736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An analysis of nuclear DNA histogram of adenocarcinoma of the uterine cervix].
    Yoshida K
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):723-8. PubMed ID: 2768967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA index as prognostic factor in breast cancer.
    Rzymowska J; Skierski J; Kurylcio L; Dyrda Z
    Neoplasma; 1995; 42(5):239-42. PubMed ID: 8552202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spectrophotometrical studies of DNA quantity in epithelial cells of the human mammary gland under pre-tumor and cancer conditions].
    Ganina KP; Gudim-Levkovich KA; Lysiuk LP; Naleskina LA; Loboda VI
    Tsitologiia; 1968 Aug; 10(8):981-7. PubMed ID: 5720857
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictive value of flow cytometry for metastatic potential in breast cancer.
    Schmidt H; Wei JP; Yeh KA
    Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.
    Kuukasjärvi T; Karhu R; Tanner M; Kähkönen M; Schäffer A; Nupponen N; Pennanen S; Kallioniemi A; Kallioniemi OP; Isola J
    Cancer Res; 1997 Apr; 57(8):1597-604. PubMed ID: 9108466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.